Literature DB >> 20177709

Demographics of paediatric renal replacement therapy in Europe: 2007 annual report of the ESPN/ERA-EDTA registry.

Karlijn J van Stralen, E Jane Tizard, Enrico Verrina, Franz Schaefer, Kitty J Jager.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20177709      PMCID: PMC2874035          DOI: 10.1007/s00467-010-1472-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.

The ESPN/ERA-EDTA registry

Few data are available regarding the epidemiology of end-stage renal disease (ESRD) in children. The European Society of Paediatric Nephrology (ESPN), in collaboration with the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA), has recently established a meta-registry of European paediatric patient registries [1]. Thirty European countries reported individual patient data with information on date of birth, gender, start date renal replacement therapy (RRT), treatment modality at the start, changes in treatment, and important events such as death and transfer out of registry. Here we provide the first demographic information obtained by the ESPN/ERA-EDTA registry, relating to the calendar year 2007, including data from 28 countries. Hungary provided data for 86%, and Russia for 50% of the population; the demographic figures from these countries were extrapolated accordingly. As Italy only provided information on those starting on dialysis, this country was omitted from the calculation of the transplantation-specific incidence and prevalence. As the majority of countries (Belarus, Croatia, Czech Republic, Estonia, FYR of Macedonia, Hungary, Italy, Latvia, Lithuania, Montenegro, Poland, Portugal, Russia, Serbia, Slovakia, Slovenia, and the United Kingdom) collected information mainly from paediatric centres, information on individuals 15–17 years could be incomplete. In order to provide a valid comparison between countries, reporting has therefore been restricted to patients younger than 15 years of age. Incidence was defined as the number of new patients starting RRT in 2007, and the point prevalence was given by the total number of patients on RRT on 31 December 2007 [2]. Both incidence and prevalence were expressed in absolute numbers and per million age-related population (pmarp). Furthermore, to allow calculations of the number of children on RRT based on population data, results were also expressed per million total population, including adults (pmtp).

Incidence of paediatric RRT across Europe

In 2007, the overall incidence rate of RRT among children under the age of 15 was 6.5 pmarp, which was 1.0 pmtp. The median reported incidence by region/country was 6.5 pmarp (interquartile range 3.7–7.8). The incidence was highest in adolescence (8.0 pmarp; age group 10–14 years), lowest in mid-childhood (4.6 pmarp), and intermediate (6.7 pmarp) in children younger than 5 years of age. RRT incidence was almost 50% higher in males (7.5 pmarp) than in females (5.4 pmarp). The modality-specific incidences were 2.8 pmarp for peritoneal dialysis, 2.4 pmarp for haemodialysis, 1.0 pmarp for pre-emptive transplantation and unknown for 0.3 pmarp (Table 1).
Table 1

Incidence of paediatric patients accepted for renal replacement therapy (RRT) in 2007 and general population characteristics of countries contributing 2007 data to the European Society for Paediatric Nephrology/European Renal Association—European Dialysis and Transplant Association (ESPN/ERA-EDTA) registry

CountryRRT patientsGeneral population
0–14 years0–14 years
CountpmarpCount
Austria107.71,296,776
Belarus107.01,421,557
Croatia22.9686,967
Czech Republic96.11,478,219
Denmark54.91,025,793
Estonia00.0199,223
Finland1112.3897,885
France776.511,767,559
FYR of Macedonia37.9381,868
Greece138.11,598,665
Hungarya 32.31,306,536
Iceland115.265,633
Italyb 354.28,350,585
Latviac 13.2315,386
Lithuania35.7527,561
Montenegro00123,048
The Netherlands227.52,947,170
Norway33.3906,655
Poland416.95,961,618
Portugalc 169.81,633,245
Romania82.43,298,815
Russiaa 817.810,426,340
Serbia54.41,142,760
Slovakia44.6860,833
Slovenia27.1281,081
Spain, Andalusia107.61,316,682
Spain, Aragon211.7170,569
Spain, Basque13.7271,786
Spain, Catalonia43.81,046,915
Spain, Valencia79.9707,577
Sweden117.11,545,660
United Kingdom837.710,721,100
Total4836.574,682,067

Incident rates may vary over the years due to random variation because of small numbers

aAssuming 86% coverage of general population for Hungary and 50% coverage for Russia

b Pre-emptive transplantation not included

c Only patients from paediatric centres included

Incidence of paediatric patients accepted for renal replacement therapy (RRT) in 2007 and general population characteristics of countries contributing 2007 data to the European Society for Paediatric Nephrology/European Renal Association—European Dialysis and Transplant Association (ESPN/ERA-EDTA) registry Incident rates may vary over the years due to random variation because of small numbers aAssuming 86% coverage of general population for Hungary and 50% coverage for Russia b Pre-emptive transplantation not included c Only patients from paediatric centres included

Prevalence of paediatric RRT across Europe

The overall point prevalence of paediatric RRT on 31 December 2007 was 33.6 pmarp, which was 5.4 pmtp. The median prevalence across countries and regions was 31.1 pmarp, with an interquartile range of 24.5 to 41.6 pmarp. Prevalence increased more than threefold from the infant to the adolescent age group. More than half of the patients had a functioning kidney allograft (20.1 pmarp), whereas 7.4 patients pmarp were on peritoneal dialysis and 4.8 on haemodialysis. Treatment modality was unknown in 1.4 patients pmarp (Table 2).
Table 2

Prevalence of paediatric patients on renal replacement therapy (RRT) on 31 December 2007. Prevalence counts and prevalence per million age-related population by age and gender in countries contributing 2007 data to the European Society for Paediatric Nephrology/European Renal Association—European Dialysis and Transplant Association (ESPN/ERA-EDTA) data registry

CountryTotal (years)Age groups (years)Gender (years)Treatment modalityd (years)
RRT patientsMalesFemalesHDPDTx
0–140–45–910–140–140–140–140–140–14
Countpmarppmarppmarppmarppmarppmarppmarppmarppmarp
Austria5441.617.550.354.349.633.32.33.935.5
Belarus1913.38.717.613.413.612.92.89.80.7
Croatia1927.714.617.547.431.223.92.911.613.1
Czech Republic3322.319.815.530.721.123.61.48.812.2
Denmark3837.015.238.456.045.728.03.91.931.2
Estonia210.00.016.214.89.810.3010.00
Finland8392.479.393.8103.0102.581.91.110.081.3
France40134.115.529.357.941.726.15.02.326.4
FYR of Macedonia718.30.016.134.625.410.8018.30
Greece4628.89.333.143.934.023.25.610.013.1
Hungarya 3728.37.221.752.538.817.31.53.123.7
Iceland230.50.094.10.00.062.10030.5
Italyb 24729.618.231.838.733.825.12.67.7na
Latviac 26.30.010.58.96.26.506.30
Lithuania1732.219.723.848.244.419.411.49.511.4
Montenegro18.10.024.70.015.70.0008.1
The Netherlands13144.418.845.668.252.436.17.86.430.2
Norway4246.324.039.973.256.036.21.1045.2
Poland23038.622.738.751.245.229.36.518.612.4
Portugalc 6439.222.145.549.947.730.21.219.618.4
Romania3510.61.97.321.98.912.45.84.20.6
Russiaa 16816.15.514.029.116.315.95.53.76.6
Serbia2824.55.427.439.532.416.26.11.816.6
Slovakia2326.77.625.843.127.226.24.611.610.5
Slovenia621.310.933.020.427.714.67.110.73.6
Spain, Andalusia4131.16.825.760.433.928.21.52.327.3
Spain, Aragon635.234.017.953.845.624.20035.2
Spain, Basque2695.720.0134.0145.5100.390.83.77.484.6
Spain, Catalonia4845.831.046.962.755.635.45.71.938.2
Spain, Valencia2941.032.834.655.954.926.27.14.229.7
Sweden7548.530.844.568.555.541.21.35.242.1
United Kingdom55251.523.146.783.460.841.16.811.824.0
Total251233.616.432.251.539.227.54.87.420.1e

HD haemodialysis, PD peritoneal dialysis, Tx transplantation

aAssuming 86% coverage of the general population for Hungary, 50% for Russia

bPre-emptive transplantation not included

cOnly patients from paediatric centres included

dPatients with unknown treatment modalities excluded

ePatients from Italy excluded

Prevalence of paediatric patients on renal replacement therapy (RRT) on 31 December 2007. Prevalence counts and prevalence per million age-related population by age and gender in countries contributing 2007 data to the European Society for Paediatric Nephrology/European Renal Association—European Dialysis and Transplant Association (ESPN/ERA-EDTA) data registry HD haemodialysis, PD peritoneal dialysis, Tx transplantation aAssuming 86% coverage of the general population for Hungary, 50% for Russia bPre-emptive transplantation not included cOnly patients from paediatric centres included dPatients with unknown treatment modalities excluded ePatients from Italy excluded

Conclusions

The data contributed by 32 registries from 28 European countries by the end of 2007 allowed us to calculate current demographic figures for paediatric RRT across the continent. Both incidence and prevalence of RRT are about 20 times lower in children compared with adults [3]. In comparison to the last demographic report of the former EDTA registry 14 years ago [4], we found nearly threefold higher incidence and prevalence of RRT among children aged younger than 15 years. This difference is likely to be due to the critical underreporting to the previous registry based on questionnaire collection from individual centres. However, it may in some part also reflect a recent achievement of RRT programmes for all children in many countries and an increasing acceptance and survival of infants and children with multiple comorbidities in paediatric RRT programmes, resulting in a truly increased incidence and prevalence of RRT. Nevertheless, information extracted from the report on paediatric RRT of the current ERA-EDTA registry [5], which comprised data collected in 2000 from 11 western European countries, showed that children younger than 15 years had a very similar incidence and slightly higher prevalence compared with data presented in this report.
  5 in total

1.  Measuring disease occurrence.

Authors:  K J Jager; C Zoccali; R Kramar; F W Dekker
Journal:  Kidney Int       Date:  2007-06-20       Impact factor: 10.612

Review 2.  Report on management of renal failure in Europe, XXV, 1994. The child-adult interface. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association.

Authors:  O Mehls; S Rigden; J H Ehrich; F Berthoux; E H Jones; F Valderrábano
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

3.  Renal replacement therapy in children: data from 12 registries in Europe.

Authors:  Bert J van der Heijden; Paul C W van Dijk; Kate Verrier-Jones; Kitty J Jager; J Douglas Briggs
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

4.  Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF).

Authors:  E Jane Tizard; Enrico Verrina; Karlijn J van Stralen; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2009-06-27       Impact factor: 5.992

5.  The 2007 ERA-EDTA Registry Annual Report-a Précis.

Authors:  Vianda S Stel; Anneke Kramer; Carmine Zoccali; Kitty J Jager
Journal:  NDT Plus       Date:  2009-09-11
  5 in total
  12 in total

Review 1.  Strategies to optimize kidney recovery and preservation in transplantation: specific aspects in pediatric transplantation.

Authors:  Tackwa Khalifeh; Edouard Baulier; Sylvain Le Pape; Thomas Kerforne; Remy Coudroy; Souleymane Maiga; Thierry Hauet; Michel Pinsard; Frederic Favreau
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

2.  End-stage renal disease in Japanese children: a nationwide survey during 2006-2011.

Authors:  Motoshi Hattori; Mayumi Sako; Tetsuji Kaneko; Akira Ashida; Akira Matsunaga; Tohru Igarashi; Noritomo Itami; Toshiyuki Ohta; Yoshimitsu Gotoh; Kenichi Satomura; Masataka Honda; Takashi Igarashi
Journal:  Clin Exp Nephrol       Date:  2015-01-17       Impact factor: 2.801

3.  End-stage renal disease in Slovak children: epidemiology from a European perspective.

Authors:  Gabriel Kolvek; Sijmen A Reijneveld; Ludmila Podracka; Jaroslav Rosenberger; Iveta Nagyova; Roy E Stewart; Jitse P van Dijk
Journal:  Eur J Pediatr       Date:  2011-04-08       Impact factor: 3.183

Review 4.  Hemodialysis in children with end-stage renal disease.

Authors:  Dominik Müller; Stuart L Goldstein
Journal:  Nat Rev Nephrol       Date:  2011-09-06       Impact factor: 28.314

Review 5.  Lessons learned from the ESPN/ERA-EDTA Registry.

Authors:  Jérôme Harambat; Marjolein Bonthuis; Jaap W Groothoff; Franz Schaefer; E Jane Tizard; Enrico Verrina; Karlijn J van Stralen; Kitty J Jager
Journal:  Pediatr Nephrol       Date:  2015-10-24       Impact factor: 3.714

6.  Overview of the Canadian pediatric end-stage renal disease database.

Authors:  Susan M Samuel; Marcello A Tonelli; Bethany J Foster; Alberto Nettel-Aguirre; Yingbo Na; Robert Williams; Andrea Soo; Brenda R Hemmelgarn
Journal:  BMC Nephrol       Date:  2010-08-26       Impact factor: 2.388

7.  Incidence and causes of end-stage renal disease among Aboriginal children and young adults.

Authors:  Susan M Samuel; Bethany J Foster; Brenda R Hemmelgarn; Alberto Nettel-Aguirre; Lynden Crowshoe; R Todd Alexander; Andrea Soo; Marcello A Tonelli
Journal:  CMAJ       Date:  2012-08-27       Impact factor: 8.262

8.  Implementation of clinical pharmacy services in a pediatric dialysis unit.

Authors:  Radwa El Borolossy; Lamia El Wakeel; Ihab El Hakim; Osama Badary
Journal:  Pediatr Nephrol       Date:  2014-02-16       Impact factor: 3.714

9.  Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry.

Authors:  Franz Schaefer; Dagmara Borzych-Duzalka; Marta Azocar; Reyner Loza Munarriz; Lale Sever; Nejat Aksu; Lorena Sànchez Barbosa; Yajaira Silva Galan; Hong Xu; Paula A Coccia; Attila Szabo; William Wong; Rosana Salim; Enrico Vidal; Stephen Pottoore; Bradley A Warady
Journal:  Perit Dial Int       Date:  2012 Jul-Aug       Impact factor: 1.756

10.  Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5).

Authors:  Aleksandra M Zurowska; Michel Fischbach; Alan R Watson; Alberto Edefonti; Constantinos J Stefanidis
Journal:  Pediatr Nephrol       Date:  2012-10-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.